{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:53:11Z","timestamp":1791193991993,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007251","name":"National Research University Higher School of Economics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007251","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"\n Background<\/jats:title>\n Differential diagnosis between pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) is crucial for treatment selection, particularly regarding surgical intervention. The prevalence of hereditary thrombophilias in Russian CTEPH patients and the utility of genetic data in differential diagnosis remain understudied.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To evaluate the prevalence of inherited thrombophilia among patients with CTEPH and PAH, to benchmark the results against published data from other cohorts, and to assess the potential utility of integrating genetic findings and polygenic risk score (PRS) parameters with clinical data for differentiating CTEPH from PAH.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n The study included 390 patients (252 PAH, 138 CTEPH). Whole-genome sequencing was performed to analyze classical thrombophilia genes (\n PROC, PROS<\/jats:italic>\n 1\n , SERPINC<\/jats:italic>\n 1\n , F<\/jats:italic>\n 2\n , F<\/jats:italic>\n 5\n , ADAMTS<\/jats:italic>\n 13\n , HRG, JAK<\/jats:italic>\n 2\n , PIGA, THBD, F<\/jats:italic>\n 9\n , FGA, FGB, FGG, CALR<\/jats:italic>\n ) and calculate VTE polygenic risk scores. A meta-analysis of 15 studies on hereditary thrombophilia prevalence in CTEPH was conducted. AutoML algorithm was used to construct diagnostic models.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Rare variants in thrombosis-associated genes were significantly more prevalent in patients with CTEPH than in those with PAH (12.3% vs. 1.2%,\n p<\/jats:italic>\n \u2009&lt;\u20090.001). Similarly, carriers of the common F5 and F2 thrombophilia variants were more frequent in the CTEPH group (15.9% vs. 6.3%,\n p<\/jats:italic>\n \u2009=\u20090.002). Meta-analysis yielded pooled prevalence estimates in CTEPH of 3.0% for antithrombin deficiency, 3.6% for protein S deficiency, 4.7% for protein C deficiency, 7.9% for F5 Leiden, and 5.6% for F2 G20210A; these estimates were consistent with those reported in other populations. The clinical model yielded an ROC AUC of 0.883. The addition of PGS004854 and rare variants in thrombosis-associated genes increased the AUC to 0.951, representing an absolute increase of 0.068 (7.7%;\n p<\/jats:italic>\n \u2009=\u20090.026). In the multivariable model, PGS004854 was the strongest positive genetic predictor of CTEPH (\n \u03b2<\/jats:italic>\n \u2009=\u20091.869,\n p<\/jats:italic>\n \u2009&lt;\u20090.001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The genetic profile of CTEPH patients differs significantly from PAH, with a higher frequency of hereditary thrombotic risk factors. Integrating clinical data with polygenic risk scores and thrombophilia variants improves differential diagnosis accuracy and may optimize the clinical workup.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1887880","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:08:35Z","timestamp":1791191315000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integration of hereditary thrombophilia data and polygenic risk scores into prognostic models improves differential diagnosis of CTEPH"],"prefix":"10.3389","volume":"13","author":[{"given":"Yaroslav","family":"Kubkin","sequence":"first","affiliation":[{"name":"Centre for Biomedical Research and Technologies, Institute of Artificial Intelligence and Digital Sciences, HSE University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Nikulin","sequence":"additional","affiliation":[{"name":"City Clinical Hospital No 29 by N.E. Bauman","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Okhrimenko","sequence":"additional","affiliation":[{"name":"Centre for Biomedical Research and Technologies, Institute of Artificial Intelligence and Digital Sciences, HSE University","place":["Moscow, Russia"]},{"name":"Faculty of Physics, Lomonosov Moscow State University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Minushkina","sequence":"additional","affiliation":[{"name":"City Clinical Hospital No 29 by N.E. Bauman","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizaveta","family":"Dyachkova","sequence":"additional","affiliation":[{"name":"City Clinical Hospital No 29 by N.E. Bauman","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lyzhenkova","sequence":"additional","affiliation":[{"name":"City Clinical Hospital No 29 by N.E. Bauman","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Danilova","sequence":"additional","affiliation":[{"name":"City Clinical Hospital No 29 by N.E. Bauman","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Dankovtseva","sequence":"additional","affiliation":[{"name":"City Clinical Hospital No 29 by N.E. Bauman","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Borovikova","sequence":"additional","affiliation":[{"name":"Centre for Biomedical Research and Technologies, Institute of Artificial Intelligence and Digital Sciences, HSE University","place":["Moscow, Russia"]},{"name":"Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Zamyatin","sequence":"additional","affiliation":[{"name":"Centre for Biomedical Research and Technologies, Institute of Artificial Intelligence and Digital Sciences, HSE University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Averyanov","sequence":"additional","affiliation":[{"name":"City Clinical Hospital No 29 by N.E. Bauman","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Poptsova","sequence":"additional","affiliation":[{"name":"Centre for Biomedical Research and Technologies, Institute of Artificial Intelligence and Digital Sciences, HSE University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Zateyshchikov","sequence":"additional","affiliation":[{"name":"City Clinical Hospital No 29 by N.E. Bauman","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2401324","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur Respir J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ijcard.2012.10.026","article-title":"Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the compera registry","volume":"168","author":"Hoeper","year":"2013","journal-title":"Int J Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1016\/j.jtha.2024.09.006","article-title":"Incidence and clinical course of chronic thromboembolic pulmonary hypertension with or without a history of venous thromboembolism in Denmark","volume":"22","author":"Klok","year":"2024","journal-title":"J Thromb Haemost"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2401370","DOI":"10.1183\/13993003.01370-2024","article-title":"Genetics and precision genomics approaches to pulmonary hypertension","volume":"64","author":"Austin","year":"2024","journal-title":"Eur Respir J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (Esc) and the European respiratory society (ERS). endorsed by the international society for heart and lung transplantation (ISHLT) and the European reference network on rare respiratory diseases (ERN-lung)","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/jth.15109","article-title":"Recommendations for clinical laboratory testing for protein S deficiency: communication from the ssc committee plasma coagulation inhibitors of the isth","volume":"19","author":"Marlar","year":"2021","journal-title":"J Thromb Haemost"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B9","year":""},{"key":"B10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nbt.4235","article-title":"A universal SNP and small-indel variant caller using deep neural networks","volume":"36","author":"Poplin","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/cge.14516","article-title":"Genebe.Net: implementation and validation of an automatic acmg variant pathogenicity criteria assignment","volume":"106","author":"Stawi\u0144ski","year":"2024","journal-title":"Clin Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jtha.2023.11.011","article-title":"Evaluating the clinical validity of genes related to hemostasis and thrombosis using the clinical genome resource gene curation framework","volume":"22","author":"Ross","year":"2024","journal-title":"J Thromb Haemost"},{"key":"B15","doi-asserted-by":"publisher","first-page":"109664","DOI":"10.1016\/j.thromres.2026.109664","article-title":"Functional and structural consequences of fibrinogen gamma-chain variants associated with thrombotic phenotype in congenital fibrinogen disorders","volume":"260","author":"Simurda","year":"2026","journal-title":"Thromb Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"19838","DOI":"10.1038\/s41598-019-56236-x","article-title":"CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms","volume":"9","author":"Belcic Mikic","year":"2019","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/gim.2017.26","article-title":"Using high-resolution variant frequencies to empower clinical genome interpretation","volume":"19","author":"Whiffin","year":"2017","journal-title":"Genet Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1001\/jama.2025.0155","article-title":"Population-scale studies of protein S abnormalities and thrombosis","volume":"333","author":"Chaudhry","year":"2025","journal-title":"JAMA"},{"key":"B19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jtha.2024.12.006","article-title":"Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening","volume":"23","author":"Suchon","year":"2025","journal-title":"J Thromb Haemost"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41588-019-0519-3","article-title":"Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease","volume":"51","author":"Klarin","year":"2019","journal-title":"Nat Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"100241","DOI":"10.1016\/j.xgen.2022.100241","article-title":"Global biobank analyses provide lessons for developing polygenic risk scores across diverse cohorts","volume":"3","author":"Wang","year":"2023","journal-title":"Cell Genom"},{"key":"B22","doi-asserted-by":"publisher","first-page":"21340","DOI":"10.1038\/s41598-021-00796-4","article-title":"Prediction of primary venous thromboembolism based on clinical and genetic factors within the U.K. Biobank","volume":"11","author":"Kolin","year":"2021","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.ajhg.2022.10.009","article-title":"Systematic comparison of family history and polygenic risk across 24 common diseases","volume":"109","author":"Mars","year":"2022","journal-title":"Am J Hum Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1111\/jth.15879","article-title":"Genetic risk and incident venous thromboembolism in middle-aged and older adults following COVID-19 vaccination","volume":"20","author":"Xie","year":"2022","journal-title":"J Thromb Haemost"},{"key":"B25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41588-022-01286-7","article-title":"Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolism","volume":"55","author":"Ghouse","year":"2023","journal-title":"Nat Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0280657","DOI":"10.1371\/journal.pone.0280657","article-title":"Prediction of venous thromboembolism incidence in the general adult population using two published genetic risk scores","volume":"18","author":"Folsom","year":"2023","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s42003-024-05874-7","article-title":"Integration of risk factor polygenic risk score with disease polygenic risk score for disease prediction","volume":"7","author":"Jung","year":"2024","journal-title":"Commun Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"100523","DOI":"10.1016\/j.xgen.2024.100523","article-title":"Integrative polygenic risk score improves the prediction accuracy of complex traits and diseases","volume":"4","author":"Truong","year":"2024","journal-title":"Cell Genom"},{"key":"B29","first-page":"1","article-title":"\u201cSystematic reviews of prevalence and incidence\u201d","volume-title":"Joanna Briggs Institute Reviewer\u2019s manual Adelaide","author":"Munn","year":"2017"},{"key":"B30","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The prisma 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamasurg.2021.0522","article-title":"MOOSE reporting guidelines for meta-analyses of observational studies","volume":"156","author":"Brooke","year":"2021","journal-title":"JAMA Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"818574","DOI":"10.3389\/fgene.2022.818574","article-title":"Calculating polygenic risk scores (PRS) in UK biobank: a practical guide for epidemiologists","volume":"13","author":"Collister","year":"2022","journal-title":"Front Genet"},{"key":"B33","author":"Erickson","year":"2020"},{"key":"B34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jacasi.2022.02.010","article-title":"Prevalence, genetic background, and clinical phenotype of congenital thrombophilia in chronic thromboembolic pulmonary hypertension","volume":"2","author":"Lian","year":"2022","journal-title":"JACC Asia"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1182\/blood-2013-04-499335","article-title":"Protein S levels and the risk of venous thrombosis: results from the mega case-control study","volume":"122","author":"Pintao","year":"2013","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1160\/TH11-12-0875","article-title":"Deficiencies of antithrombin, protein C and protein S\u2013practical experience in genetic analysis of a large patient cohort","volume":"108","author":"Caspers","year":"2012","journal-title":"Thromb Haemostasis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ajh.26413","article-title":"Molecular and clinical characterization of transient antithrombin deficiency: a new concept in congenital thrombophilia","volume":"97","author":"Bravo-P\u00e9rez","year":"2022","journal-title":"Am J Hematol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","article-title":"Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry","volume":"124","author":"Pepke-Zaba","year":"2011","journal-title":"Circulation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.chest.2021.05.052","article-title":"Results from the United States chronic thromboembolic pulmonary hypertension registry: enrollment characteristics and 1-year follow-up","volume":"160","author":"Kerr","year":"2021","journal-title":"Chest"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1887880\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:08:37Z","timestamp":1791191317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1887880\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":39,"alternative-id":["10.3389\/fcvm.2026.1887880"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1887880","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1887880"}}